3 reports

The survival rate for some of the cancers after five years of diagnosis and treatment is very low-for pancreatic cancer, ##%; liver cancer, ##%; lung cancer, ##%; esophageal cancer, ##%; and stomach cancer, ##% (American Cancer Society).

  • Genetic Disorder
  • Pharmaceutical
  • North America
  • United States
  • Market Size

IT WAS UNDER DEVELOPMENT FOR THE TREATMENT OF NONSMALL CELL LUNG CANCER, METASTATIC BREAST CANCER, PROSTATE CANCER, METASTATIC OR UNRESECTABLE ADENOCARCINOMA OF ESOPHAGUS, GASTROESOPHAGEAL JUNCTION AND STOMACH CANCER.

  • Chronic Disease
  • Genetic Disorder
  • United States
  • Company
  • Product Initiative
  • KITS AND REAGENTS SEGMENT TO GROW AT THE HIGHEST CAGR IN THE
  • INCIDENCE OF CANCER, BY COUNTRY (2012)

Prostate cancer is the leading cause of cancer death among males, with about ##, ## deaths annually, followed by lung and stomach cancers.

  • Genetic Disorder
  • North America
  • United States
  • Market Size
  • Agilent Technologies, Inc.